|
|
|
RESEARCH COMMUNICATION
1 Childrens Hospital, Boston, Massachusetts 02115, USA; 2 Department of Pathology, Brigham and Womens Hospital, Boston, Massacusetts 02115, USA
| Abstract |
|---|
|
|
|---|
[Keywords: Cancer; chromosome segregation; mitotic checkpoint; zebrafish]
Received July 18, 2006; revised version accepted November 8, 2006.
| Results and Discussion |
|---|
|
|
|---|
|
30% of the cells are polyploid, which is similar to the level seen in cds homozygous mutants (Fig. 1E). These data strongly suggest it is a loss of function of separase that is responsible for the cds phenotype.
Loss of separase in yeast, human, and mouse cells has been shown to cause mitotic spindle defects such as multiple spindle poles (Baum et al. 1988
; Uzawa et al. 1990
; Waizenegger et al. 2002
; Chestukhin et al. 2003
; Kumada et al. 2006
; Wirth et al. 2006
). Examination of the mitotic spindle in 32-hpf cds mutants demonstrated that
50% of the visible spindles were abnormal (Fig. 2AI; data not shown). Analysis of cds cells for pH3 and mitotic spindles showed that these abnormal mitotic figures do exhibit multipolar spindles some with three to four visible centrosomes (Fig. 2B, DH). Monopolar spindles are also visible (Fig. 2C). Also present are multipolar spindles that appear to have lobed or distinct nuclei with spindles that may nucleate from shared centrosomes (Fig. 2G,H). These may represent failed mitoses resulting from fused cells or midbody retraction. Another defect commonly seen in cds embryos is lagging chromosomes (Fig. 2I). This phenotype has also been seen in Separase knockdowns in human cells (Chestukhin et al. 2003
). Our findings indicate that separase is required for normal chromosome segregation in zebrafish, and supports a conserved role in regulating mitosis in eukaryotic cells.
|
To further characterize the polyploidy seen in cds embryos and to look for further evidence of chromosomal instability as indicated by the presence of grossly abnormal mitoses, interphase fluorescent in situ hybridization (FISH) analysis was performed using probes specific to two randomly chosen linkage groups. This analysis shows that cds embryos contain 48% polyploid and 34% aneuploid cells versus 2% and 7%, respectively, in wild types (Fig. 3A,B). Further analysis of metaphase spreads demonstrated the presence of cells in cds mutant embryos with 16N DNA content (Fig. 3C). These cells also contain diplochromosomes (chromosomes that have undergone DNA replication but have not segregated) that appear to remain attached at the centromeres. Diplochromosomes have been previously observed in Drosophila, and more recently in mouse, separase mutants (Jager et al. 2001
; Kumada et al. 2006
). This confirms the role of vertebrate Separase in cleavage of the bonds between sister chromatids during mitotis.
|
|
Heterozygous mutations in tumor suppressor genes often contribute to tumor formation through a mechanism of loss of heterozygosity. To determine if this mechanism was applicable to the epithelial tumors arising in the separase heterozygotes, we performed FISH on 10 epithelial tumors from cds heterozygotes using a probe that contained the separase locus and a centromeric control probe from the same linkage group. In two large and advanced epithelial tumors we found a single copy of separase and two copies of the control centromeric probe (in
70% of the cells in each tumor, n = 200 cells) (Fig. 4G; Supplementary Fig. S4), indicating loss of one allele of the separase gene. Sequence analysis of laser-capture microdissected tissue from the tumor depicted in Figure 4G indicated that the wild-type allele was lost (Supplementary Fig. S5). Areas outside the tumor margins had two copies of each probe (Fig. 4H; Supplementary Fig. S4). It is also possible that loss of function of separase occurs in some of the tumors by a mechanism other than deletion, such as point mutation or silencing, although sequencing of the conserved protease domain in three epithelial tumors did not reveal any mutations (data not shown). There is no apparent polyploidy in the tumor cells with separase loss of heterozygosity (LOH) (Fig. 4G; Supplementary Fig. S4; data not shown). The zebrafish system currently does not have a platform technology to comprehensively assess global chromosomal instability. Until a comprehensive approach is possible, we cannot be certain whether instability exists in these tumors. Our data clearly demonstrates that heterozygous loss of separase contributes to initiation and progression of epithelial tumors. While haploinsufficiency of the separase gene appears to be the mechanism for the increased tumor incidence in the majority of cases, loss of heterozygosity of the separase gene appears to play a role in tumor progression in some tumors. Tumor formation may be achieved by similar mechanisms in both instances. In many environments, complete loss of separase function would likely have a negative effect on cell viability because of gross chromosomal missegregation. It is possible that only after additional mutations have occurred in the tumor that affect the cell cycle and mitotic control would loss of the functional allele of separase give a selective advantage to the tumor cells and advance tumor progression. Therefore, in more advanced tumors, complete loss of function could provide a competitive advantage for the tumor cells, enough to see LOH at some frequency. The absence of polyploidy in these tumors suggests that the cells have developed a way to partially compensate for complete loss of separase. This supports our notion that genetic lesions in the advanced tumor leads to a selective advantage for complete separase loss. While LOH is observed in some tumors, our data demonstrates that loss of only one copy of separase is sufficient in most cases to promote tumorigenesis and shift tumor spectrum toward epithelial neoplasms.
These data represent the first link between separase and increased cancer susceptibility and the first evidence that separase acts as a tumor suppressor. The presence of genomic instability and severe mitotic abnormalities in cds homozygous mutant embryos also demonstrates that zebrafish separase functions in a similar capacity to its mammalian and yeast counterparts. It is possible that separase may also act as a tumor suppressor in humans, although initial sequencing of the separase locus in 82 human tumor cells lines representing a myriad of tumor types did not reveal any obvious mutations (data not shown). The identification of Securin as a human oncogene does support a role for this pathway in human tumor formation. A more focused sequencing approach concentrating on tumors of epithelial origin may have to be undertaken in order to reveal such a role in humans.
This work also suggests interesting implications for the study of the interactions between carcinogens and genetic mutations. In zebrafish, carrying separase mutations causes a clear susceptibility to cancers outside the normal tumor spectrum when exposed to the carcinogen, MNNG. Examples of this type of specific genetic susceptibility to carcinogens have already been shown to exist in certain cases (Bennett et al. 1999
; Tan et al. 2000
). Therefore, in addition to providing the first evidence of separase tumor suppressor function, our studies demonstrate that zebrafish can serve as an excellent model system for the study of epithelial cancers, and could provide insight into the interactions between carcinogens and genetic predispositions.
| Material and methods |
|---|
|
|
|---|
pH3 staining, TUNEL staining, BrdU incoporation, DNA content analysis, and mitotic spindle/centromere staining were done as previously described (Shepard et al. 2005
).
Genetic mapping, genotyping, and library screens
cds wik strains were outcrossed to AB to create polymorphic mapping strains. Low-resolution mapping was done using pools of 40 diploid mutant and 40 diploid wild-type embryos and scanning for linked polymorphic markers using a range of CA microsatellite markers on each linkage group. After linkage was established to LG 6, CA microsatellites on this linkage group were tested for polymorphism in mapping families and then tested on a medium resolution panel of 88 mutants and eight wild types. Close flanking markers z5294 and z265 were identified, and then the entire mapping panel consisting of
1500 diploid cds embryos was tested with both markers. Recombinants were identified for both markers. ESTs in that region on the RH panel map and additional microsatellite markers were scanned for polymorphisms and close flanking markers of z11919 and z7248 were identified. A chromosomal walk was initiated from z11919. Overgo oligos were designed from BAC end sequence and hybridized to CHORI and DanioKey BAC library filters. Polymorphic markers were identified on BAC ends by SSCP analysis. BAC end sequence was used to identify a BAC in the critical interval that contained the cds locus and the entire separase gene.
cds RFLP genotyping
Genomic DNA was extracted from embryos or adult tailclips and amplified with nested PCR primers flanking the cds mutation (forward primer1, 5'-GACACACGCCTGAGGTAAC-3'; reverse primer1, 5'-CAT AACCCTTAAACATTTTCCTG-3'; forward primer2, 5'-CGGGTTAG GAGAATCCTTAG-3'; reverse primer2, 5'-TGTATGCAAGTCTCGA GTGG-3'). The initial PCR conditions were as follows: 20 sec at 94°C, 30 sec at 65°C (decrease 0.5°C per cycle), 1 min at 72°C for 30 cycles and then an additional 10 cycles of 20 sec at 94°C, 30 sec at 58°C, and 1 min at 72°C. The second nested PCR conditions were 20 sec at 94°C, 30 sec at 58°C, and 1 min at 72°C for 30 cycles. The PCR products were digested for 2.5 h at 37°C with the enzyme Hpy188I (New England Biolabs), which cuts the mutant but not the wild-type allele. Digests were run on a 2.5% agarose gel and the presence of digestion fragments indicated the mutant allele.
Embryo injection experiments
Morpholinos were designed to the exon 14 splice donor site (5'-ACTG GCTGAGTGTCTGCAGTTTGGT-3') (GeneTools). One-cell stage embryos were injected into the yolk sac with 1 nL of a 500-µM solution of the splice morpholino (or control vehicle). Embryos were examined at 24 hpf for the characteristic morphology of cds as well as undergoing DNA content analysis.
Cytogenetics
Metaphase chromosome spreads and interphase nuclei were obtained from 24-hpf embryos using standard cytogenetic procedures. Cells were arrested at metaphase with colchicine, subjected to hypotonic treatments, and fixed onto glass slides with 3:1 methanol:acetic acid. Fluorescence in situ hybridization was performed using standard protocols. Fluorescently labeled probes included a rhodamine-labeled zC039P05 BAC DNA probe for linkage group 2 and a FITC-labeled zC132M17 BAC DNA probe for linkage group 16. For tumor sections, the separase locus probe was zC233B16 and the centromere probe was zK11J4.
Carcinogenesis
Twenty-eight-day-old fry from backcrosses of mutant heterozygotes were exposed to MNNG (Spitsbergen et al. 2000
) and analyzed as previously described (Shepard et al. 2005
).
Statistical methods
A Fisher exact test was used to assess whether tumor susceptibility differed between cds heterozygotes and wild-type zebrafish. All time points were combined for this calculation. All p values are two sided.
| Footnotes |
|---|
4 Departments of Pediatrics and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA. ![]()
E-MAIL zon{at}enders.tch.harvard.edu; FAX (617) 730-0222. ![]()
Supplemental material is available at http://www.genesdev.org.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1470407
| References |
|---|
|
|
|---|
Aravind, L. and Koonin, E.V. 2002. Classification of the caspase-hemoglobinase fold: Detection of new families and implications for the origin of the eukaryotic separins. Proteins 46: 355367.[CrossRef][Medline]
Atkin, N.B. 1986. Lack of reciprocal translocations in carcinomas. Cancer Genet. Cytogenet. 21: 275278.[CrossRef][Medline]
Atkin, N.B. 1989. Solid tumor cytogenetics. Progress since 1979. Cancer Genet. Cytogenet. 40: 312.[CrossRef][Medline]
Baum, P., Yip, C., Goetsch, L., and Byers, B. 1988. A yeast gene essential for regulation of spindle pole duplication. Mol. Cell. Biol. 8: 53865397.
Bennett, W.P., Alavanja, M.C., Blomeke, B., Vahakangas, K.H., Castren, K., Welsh, J.A., Bowman, E.D., Khan, M.A., Flieder, D.B., and Harris, C.C. 1999. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J. Natl. Cancer Inst. 91: 20092014.
Chang, S., Khoo, C., and DePinho, R.A. 2001. Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol. 11: 227239.[CrossRef][Medline]
Chestukhin, A., Pfeffer, C., Milligan, S., DeCaprio, J.A., and Pellman, D. 2003. Processing, localization, and requirement of human separase for normal anaphase progression. Proc. Natl. Acad. Sci. 100: 45744579.
Jager, H., Herzig, A., Lehner, C.F., and Heidmann, S. 2001. Drosophilaseparase is required for sister chromatid separation and binds to PIM and THR. Genes & Dev. 15: 25722584.
Kumada, K., Yao, R., Kawaguchi, T., Karasawa, M., Hoshikawa, Y., Ichikawa, K., Sugitani, Y., Imoto, I., Inazawa, J., and Sugawara, M., et al. 2006. The selective continued linkage of centromeres from mitosis to interphase in the absence of mammalian separase. J. Cell Biol. 172: 835846.
Nasmyth, K. 2001. Disseminating the genome: Joining, resolving, and separating sister chromatids during mitosis and meiosis. Annu. Rev. Genet. 35: 673745.[CrossRef][Medline]
Pandey, R., Heidmann, S., and Lehner, C.F. 2005. Epithelial re-organization and dynamics of progression through mitosis in Drosophila separase complex mutants. J. Cell Sci. 118: 733742.
Pidoux, A.L., Uzawa, S., Perry, P.E., Cande, W.Z., and Allshire, R.C. 2000. Live analysis of lagging chromosomes during anaphase and their effect on spindle elongation rate in fission yeast. J. Cell Sci. 113: 41774191.[Abstract]
Shepard, J.L., Amatruda, J.F., Stern, H.M., Subramanian, A., Finkelstein, D., Ziai, J., Finley, K.R., Pfaff, K.L., Hersey, C., and Zhou, Y., et al. 2005. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc. Natl. Acad. Sci. 102: 1319413199.
Sotillo, R., Hernando, E., Diaz-Rodriguez, E., Teruya-Feldstein, J., Cordon-Cardo, C., Lowe, S.W., and Benezera, R. 2006. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell (in press).
Spitsbergen, J.M., Tsai, H.W., Reddy, A., Miller, T., Arbogast, D., Hendricks, J.D., and Bailey, G.S. 2000. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol. 28: 716725.
Stegmeier, F., Visintin, R., and Amon, A. 2002. Separase, polo kinase, the kinetochore protein Slk19, and Spo12 function in a network that controls Cdc14 localization during early anaphase. Cell 108: 207220.[CrossRef][Medline]
Stemmann, O., Zou, H., Gerber, S.A., Gygi, S.P., and Kirschner, M.W. 2001. Dual inhibition of sister chromatid separation at metaphase. Cell 107: 715726.[CrossRef][Medline]
Tan, W., Song, N., Wang, G.Q., Liu, Q., Tang, H.J., Kadlubar, F.F., and Lin, D.X. 2000. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomarkers Prev. 9: 551556.
Uzawa, S., Samejima, I., Hirano, T., Tanaka, K., and Yanagida, M. 1990. The fission yeast cut1+ gene regulates spindle pole body duplication and has homology to the budding yeast ESP1 gene. Cell 62: 913925.[CrossRef][Medline]
Viadiu, H., Stemmann, O., Kirschner, M.W., and Walz, T. 2005. Domain structure of separase and its binding to securin as determined by EM. Nat. Struct. Mol. Biol. 12: 552553.[CrossRef][Medline]
Waizenegger, I., Gimenez-Abian, J.F., Wernic, D., and Peters, J.M. 2002. Regulation of human separase by securin binding and autocleavage. Curr. Biol. 12: 13681378.[CrossRef][Medline]
Wirth, K.G., Wutz, G., Kudo, N.R., Desdouets, C., Zetterberg, A., Taghybeeglu, S., Seznec, J., Ducos, G.M., Ricci, R., and Firnberg, N., et al. 2006. Separase: A universal trigger for sister chromatid disjunction but not chromosome cycle progression. J. Cell Biol. 172: 847860.
Zou, H., McGarry, T.J., Bernal, T., and Kirschner, M.W. 1999. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285: 418422.
Zou, H., Stemman, O., Anderson, J.S., Mann, M., and Kirschner, M.W. 2002. Anaphase specific auto-cleavage of separase. FEBS Lett. 528: 246250.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. J. Okumura, L. F. Peterson, F. Okumura, A. Boyapati, and D.-E. Zhang t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression Blood, August 15, 2008; 112(4): 1392 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feitsma and E. Cuppen Zebrafish as a Cancer Model Mol. Cancer Res., May 1, 2008; 6(5): 685 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Carradice and G. J. Lieschke Zebrafish in hematology: sushi or science? Blood, April 1, 2008; 111(7): 3331 - 3342. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Pfaff, C. T. Straub, K. Chiang, D. M. Bear, Y. Zhou, and L. I. Zon The Zebra fish cassiopeia Mutant Reveals that SIL Is Required for Mitotic Spindle Organization Mol. Cell. Biol., August 15, 2007; 27(16): 5887 - 5897. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||